Study Reported Tadalafil Taken Once Daily Improved Erectile Function in Men with ED and Sexual Quality of Life in Couples
... improved erectile function for men with erectile
dysfunction (ED) and reported improvement in the sexual ... is approved for the treatment of erectile
dysfunction on an as-needed basis or in a daily regimen. The ... or call 1-877-4-CIALIS
About Erectile
dysfunction (ED)
ED is defined as the consistent ...
Generic Substitutes Less Effective/Safe Than Branded Medications in Treating Lower Urinary Tract Symptoms
... nasal congestion (3.2 percent) and ejaculatory
dysfunction (3.6 percent) for those switching alpha blockers, and ejaculatory
dysfunction (4.7 percent) and erectile
dysfunction (5.8 percent) for those switching to generic ...
New Body of Research Suggests Statin Use Benefits Multiple Areas of Urologic Health
... benefit men with prostate cancer, erectile
dysfunction or lower urinary tract symptoms (LUTS). Several ... 925: Statin use and development of erectile
dysfunction
Statins may provide the added benefit of reducing a man's risk of developing erectile
dysfunction in association with the drug's use in vascular ...
Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
...
Post-Operative Incontinence and Erectile
dysfunction
Urinary incontinence and erectile
dysfunction are very common side effects following open or ... many men experience some degree of erectile
dysfunction following radical prostatectomy, depending on a ...
Mayo Clinic Study Finds Younger Men With Erectile Dysfunction at Double Risk of Heart Disease
... -- Men who experience erectile
dysfunction between the ages of 40 and 49 are twice as likely ...
Researchers also found that men with erectile
dysfunction have an 80 percent higher risk of heart disease. ... and their doctors may need to consider erectile
dysfunction a harbinger of future risk of coronary heart ...
AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Cognitive Dysfunction in Schizophrenia
... (TC-1734) conducted by AstraZeneca in cognitive
dysfunction in schizophrenia (CDS), known as the HALO trial. ... test battery(1).
About Cognitive
dysfunction in Schizophrenia
Schizophrenia is a ... in development for Alzheimer's disease, cognitive
dysfunction in schizophrenia, pain and depression, as well as ...
Late-Breaking Data Highlighting Research Advances in Several Blood Disorders to Be Presented At the American Society of Hematology Annual Meeting
... (6R-BH4): Novel Therapy for Endothelial
dysfunction in Sickle Cell Disease
[LBA-5]
Lewis ... The drug appears to improve endothelial
dysfunction -- the inability of blood vessels to dilate ... dose-dependent improvements in endothelial
dysfunction over 16 weeks of tetrahydrobiopterin treatment ....
BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
... whether 6R-BH4
can improve the endothelial
dysfunction observed in SCD patients. Oral
administration of ... of the patients in the trial had endothelial
dysfunction (PAT score less than or equal to 1.67), ... endothelial function. -- Endothelial
dysfunction in SCD patients treated with escalating doses ...
AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease
... being
evaluated in a Phase IIb trial in cognitive
dysfunction in schizophrenia
(the "HALO" trial), as well as a ... disorder. Top-line results from the
cognitive
dysfunction in schizophrenia trial are expected by the end ... in development
for Alzheimer's disease, cognitive
dysfunction in schizophrenia, pain and
major depressive ...
New Research Shows One in 200 People Born with DNA Mutation That Can Lead to Devastating, Often Fatal Disease
... and to learn
more about how mitochondrial
dysfunction is connected to other diseases."
Mitochondrial ... DNA mutations indicates
that mitochondrial
dysfunction is a major underlying risk factor for ... energy
production. Therefore, mitochondrial
dysfunction represents a major
unexplored area of human ...
The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds
... while 82 percent of men with erectile
dysfunction (ED) surveyed
recognize it as an indicator of ... a man's
overall health -- for instance, erectile
dysfunction can be an indicator of
other health issues," said ... not spoken
to a doctor.
About ED
Erectile
dysfunction (ED) is defined as the inability to attain and ...
New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering
... Angiotensin II has been linked to vascular
dysfunction and end-organ
damage, including cardiac ... in moderate to marked renal impairment*/hepatic
dysfunction -- In patients with possible depletion of ... of arterial structure and endothelial
dysfunction in human essential hypertension by the ...
Intra-Cellular Therapies Presents Data on Its Schizophrenia and Cognition in Schizophrenia Programs at the 14th Biennial Winter Workshop on Schizophrenia and Bipolar Disorders
... for the treatment of cognitive
dysfunction in schizophrenia. Data
characterizing the ... we are
developing ITI-002 to treat cognitive
dysfunction in schizophrenia which
remains an important ... disorders,
as widely diverse as cognitive
dysfunction in schizophrenia, attention
deficit hyperactivity ...
Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
... does not
result in concerning rates of cardiac
dysfunction in the adjuvant setting
and armed with this ... Data from the E2104 study have shown that cardiac
dysfunction is not a
major concern with the treatment ... the incidence of
clinically apparent cardiac
dysfunction in patients with lymph node
positive breast ...
MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders
... -- including depression, anxiety and executive
dysfunction -- are some
of the most disabling aspects of the ... -- Examination of the role of cognitive
dysfunction and psychiatric
disorders in disease onset, ... predict or assess early
development of cognitive
dysfunction and psychiatric disorders in PD
-- Detailed ...
New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol
... to evaluate erectile function in
erectile
dysfunction (ED) patients with dyslipidemia show that ... Background: Erectile dysfunction
Erectile
dysfunction (ED) is the consistent or recurrent inability of ... medicine that is indicated
to treat erectile
dysfunction (ED). Consistent with the effects of ...
Research Identifies Need for Improved Understanding of Sickle Cell Disease in Adulthood
... Center,
Oakland, CA
Many consider brain
dysfunction to be the most important and
least-studied ... cell pediatric patients have
neuropsychological
dysfunction -- a deficit in cognitive ability -- and
silent ... The study found that neuropsychological
dysfunction and/or undetected
brain injury affect the ...
Sexual Function Affected by Stem Cell Transplant According to Long-Term Study
... Fred Hutchinson Cancer
Research Center. "Sexual
dysfunction in survivors of cancer needs to become
a priority ... function. According to the researchers, sexual
dysfunction in transplant patients
is likely caused by ... vaginal lining that can contribute to sexual
dysfunction in women. For
males, testosterone levels and the ...
Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
... daily)
for the treatment of Opioid-Induced Bowel
dysfunction (OBD). The OBD
Pivotal Assessment of Lubiprostone ... studies are
positive. About Opioid-Induced Bowel
dysfunction (OBD) Opioid-Induced Bowel
dysfunction comprises a variety of
gastrointestinal ...
Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
... Gleevec.
Severe congestive heart failure and left ventricular
dysfunction have occasionally been reported. Most of the patients with reported ... HES and cardiac involvement, cases of cardiogenic shock/left ventricular
dysfunction have been associated with the initiation of imatinib therapy. The ...
Freezing Prostate Cancer Does a Man's Body Good
... the side effects of bladder control problems (incontinence) and erectile
dysfunction (impotence) that result from more radical prostate cancer treatments. It ... can cause side effects such as bladder control problems and erectile
dysfunction (impotence). Men are classified as being at low, intermediate or high ....
Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
... treat OIC, the most common and debilitating manifestation of opioid-bowel
dysfunction (OBD). The Phase 2 study of NKTR-118 is terminating early on the basis of ... constipation associated with other symptoms of opiate-induced bowel
dysfunction as a result of the opiate binding to the mu-opioid receptor in the gut(1). ...
Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease
... receiving
Gleevec.
Severe congestive heart failure and left ventricular
dysfunction have
occasionally been reported. Most of the patients with reported ... HES and cardiac involvement, cases of cardiogenic
shock/left ventricular
dysfunction have been associated with the initiation
of Gleevec therapy. The condition ...
Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis
... enroll 190 patients who have a diagnosis of sepsis with at least one
organ
dysfunction due to sepsis. Patients will receive standard therapy
(including, at the ... response. Severe sepsis is defined as
the presence of sepsis with
dysfunction of one or more organs. The
incidence of sepsis in the United States is ...
Dong-A PharmTech Co., Ltd. Announces Portal Hypertension Clinical Trial With Udenafil
... is thus needed.
Udenafil was approved for the treatment of erectile
dysfunction in
Korea under the brand name Zydena(R) in late December 2005 and has ... Dong-A PharmTech is continuing its development of
udenafil for erectile
dysfunction in the USA and will develop udenafil for
other indications such as benign ...
Surface Logix Achieves Objectives With SLx-2101 in Phase 2a Clinical Trial in Hypertension
... Other PDE5 inhibitors have traditionally been used to treat
erectile
dysfunction (ED). SLx-2101 was designed specifically to expand the
therapeutic ... to expand the therapeutic potential of PDE5
inhibition beyond erectile
dysfunction into larger cardiovascular markets
such as hypertension. Clinical ...
Bayer Issues Additional Guidance to Physicians on Trasylol(R)
... rare ( Trasylol administration increases the risk for renal
dysfunction and may increase the need for dialysis in the perioperative period. -- ... events: myocardial infarction, congestive heart
failure, hepatic
dysfunction and mortality. For Trasylol(R) contraindications, warnings and ...
FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
... rare ( Trasylol(R) administration increases the risk for renal
dysfunction and
may increase the need for dialysis in the perioperative period. -- ... events: myocardial infarction, congestive heart
failure, hepatic
dysfunction and mortality. For Trasylol(R) contraindications, warnings and ...
Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
... The most common adverse
events for combination therapy were erectile
dysfunction (7.4%), retrograde
ejaculation (4.2%) and altered or decreased libido (3.4%). The most common
adverse events for AVODART monotherapy were erectile
dysfunction (6.0%),
altered or decreased libido (2.8%) and breast enlargement (1.8%), ...
Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease
... the minimum rate of infusion practicable. While these reports of renal
dysfunction and acute renal failure have been associated with the use of many of the ... the minimum rate of infusion practicable. While these reports of renal
dysfunction and acute renal failure have been associated with the use of many of the ...
'Use it or Lose it': A New Theory About Preserving Erectile Function After Prostate Surgery
... BOSTON, Aug. 8 /PRNewswire-USNewswire/ -- Erectile
dysfunction after
surgery to remove the prostate (radical prostatectomy) has ... Treatment options include using a vacuum pump device or taking
erectile
dysfunction drugs by mouth or by injection into the penis. According to Dr. Marc ...
Labopharm files New Drug Submission with Health Canada for novel antidepressant
... by the first week of therapy in "overall quality of sleep" and "awakening during the night". The incidence of agitation, weight gain and sexual
dysfunction in patients administered Labopharm's trazodone was no different from placebo. The overall drop out rate in the study was 25 percent. The drop out ...
Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets
... contraindicated in patients with hypersensitivity to salicylates. Caution should be exercised when using these products in patients with known renal
dysfunction or history of renal disease. It is recommended that all patients have an evaluation of renal function prior to initiation of and periodically while ...
BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis
... of
patients studied.
"We are very pleased with the promising results of this study," says
Lasse Leino, CEO of BioCis Pharma. "Skin barrier
dysfunction is now
recognized as a hallmark feature of atopic dermatitis. Any drug showing
capacity for restoring this disturbance has significant potential in ...
Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily
... November 2008. ADCIRCA contains the same active ingredient as CIALIS(R) (tadalafil), which is marketed by Eli Lilly & Company to treat erectile
dysfunction (impotence) in more than 100 countries.
Important Safety Information for ADCIRCA
ADCIRCA should not be used in patients taking medicines ...
AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis
... Australia. It is derived from hyperimmune caprine serum and
is currently under Phase II trialling in Europe for advanced Scleroderma and
for bladder
dysfunction in Secondary Progressive Multiple Sclerosis. Both
trials are expected to report in the first quarter of 2010. Additional open
label experience with ...
Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
... creatinine or bilirubin and hepatic enzymes in some patients. Monitoring of renal and hepatic function in patients with preexisting renal or hepatic
dysfunction is recommended at least every other week during Leukine administration. Adverse events occurring in 10 percent of AML patients receiving Leukine in ...
FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
... in November 2008. ADCIRCA contains the same active ingredient as CIALIS (tadalafil), which is marketed by Eli Lilly & Company to treat erectile
dysfunction (impotence) in more than 100 countries.
Important Safety Information for ADCIRCA
ADCIRCA should not be used in patients taking ...
New Research Shows Nutrition 21's Chromium Histidinate Improves Markers for Mood and Carbohydrate Cravings
... in the development of Alzheimer's disease. Research by MCG demonstrated that high doses of chromium picolinate are safe and does not cause kidney
dysfunction in animal models of obesity and of diabetes.
James Komorowski, M.S., vice president - technical services and scientific affairs for Nutrition ...
VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction
... health, today announced that it has initiated an open label safety study (TA-314) with its investigational drug, avanafil, in males with erectile
dysfunction (ED).
VIVUS also announced today that it has completed enrollment in REVIVE (TA-301), a randomized, double-blind, placebo-controlled phase 3 ...